Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-01-04

Clinical Trial Update: Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Cascade Platelet-Rich Fibrin Matrix (PRFM) for rotator cuff healing has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cascade Platelet-Rich Fibrin Matrix (PRFM) (cascade platelet-rich fibrin matrix)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Rotator Cuff, Tendon Injuries | Phase 3 | Status: WITHDRAWN